Market Overview:
By type, the market is divided into single injection, three injection, and five injection segments. By application, it is classified into hospitals, ambulatory surgical centres (ASCs), and orthopaedic clinics segments. Geographically, it is analysed across North America (U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U.K.), Asia Pacific (Japan China India Australia South Korea) Middle East & Africa(GCC Countries Turkey Nigeria South Africa).
Product Definition:
The injection of a viscous fluid, such as hyaluronic acid, into a joint to improve the joint's function and reduce pain.
Single Injection:
The SI technique has been used in various forms for over two decades and has gained popularity due to its several advantages such as fewer incisions, reduced pain, decreased hospital stay duration and post-operative complications.
Three Injection:
The first injection is given 6 to 12 weeks after the last exercise session, second dose 3 to 6 months after the first dose and third and final injection approximately 1 year later. It helps in faster recovery from delayed-onset muscle soreness (DOMS), which occurs due to lack of activity or training for a prolonged period.
Application Insights:
Hospitals held the largest share in 2017 due to high usage of viscosupplements for knee osteoarthritis and other joint conditions. In addition, rising prevalence of obesity is also expected to contribute towards segment growth during the forecast period.
The use of viscosupplements in weight management has gained significant popularity among consumers as well as medical professionals over recent years owing to its ability to reduce adipose tissue without causing any harmful effects on liver or kidney functions. This factor is anticipated to fuel demand from end-use markets such as weight loss programs and sports nutrition supplements during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of players coupled with high demand for advanced medical products is expected to drive the regional market over the forecast period. In addition, increasing cases of joint disorders and rising awareness about viscosupplements are also expected to propel growth during the same period.
Asia Pacific is anticipated to witness significant growth over the forecast period owing to factors such as improving healthcare infrastructure and growing target population base in this region.
Europe held a substantial share in 2017 due to increased adoption by clinicians across Europe especially Germany, U.K.
Growth Factors:
- Increasing geriatric population: The global geriatric population is expected to increase from 524 million in 2010 to 1.5 billion by 2050, according to the United Nations Department of Economic and Social Affairs (UNDESA). This growing population is more susceptible to osteoarthritis, a condition that can be treated with viscosupplementation therapy.
- Rising awareness about viscosupplementation: There has been a rise in awareness about the benefits of viscosupplementation in recent years, thanks in part to increasing marketing efforts by manufacturers and healthcare professionals. This increased awareness is likely to lead more people suffering from osteoarthritis or other joint conditions to seek treatment with viscosupplements.
- Technological advances: Viscosupplementation technology continues to evolve, with new products being developed that offer improved efficacy and safety profiles compared with older treatments options. This technological progress is likely spur further growth in the market for viscusuplements over the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Viscosupplementation Market Research Report
By Type
Single Injection, Three Injection, Five Injection
By Application
Hospitals, Ambulatory Surgical Centres, Orthopaedic Clinics
By Companies
Anika Therapeutics, Sanofi, Zimmer Biomet, Meda, Ferring, Fidia Pharmaceutici, Bioventus, Anika Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
201
Number of Tables & Figures
141
Customization Available
Yes, the report can be customized as per your need.
Global Viscosupplementation Market Report Segments:
The global Viscosupplementation market is segmented on the basis of:
Types
Single Injection, Three Injection, Five Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centres, Orthopaedic Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Anika Therapeutics
- Sanofi
- Zimmer Biomet
- Meda
- Ferring
- Fidia Pharmaceutici
- Bioventus
- Anika Therapeutics
Highlights of The Viscosupplementation Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single Injection
- Three Injection
- Five Injection
- By Application:
- Hospitals
- Ambulatory Surgical Centres
- Orthopaedic Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Viscosupplementation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Viscosupplementation is the use of a viscosupplement, such as hyaluronic acid or chondroitin sulfate, to increase the viscosity of bodily fluids. This can improve blood flow and reduce inflammation.
Some of the key players operating in the viscosupplementation market are Anika Therapeutics, Sanofi, Zimmer Biomet, Meda, Ferring, Fidia Pharmaceutici, Bioventus, Anika Therapeutics.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Viscosupplementation Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Viscosupplementation Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Viscosupplementation Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Viscosupplementation Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Viscosupplementation Market Size & Forecast, 2020-2028
4.5.1 Viscosupplementation Market Size and Y-o-Y Growth
4.5.2 Viscosupplementation Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Single Injection
5.2.2 Three Injection
5.2.3 Five Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centres
6.2.3 Orthopaedic Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Viscosupplementation Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Viscosupplementation Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Single Injection
9.6.2 Three Injection
9.6.3 Five Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centres
9.10.3 Orthopaedic Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Single Injection
10.6.2 Three Injection
10.6.3 Five Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centres
10.10.3 Orthopaedic Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Single Injection
11.6.2 Three Injection
11.6.3 Five Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centres
11.10.3 Orthopaedic Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Single Injection
12.6.2 Three Injection
12.6.3 Five Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centres
12.10.3 Orthopaedic Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Single Injection
13.6.2 Three Injection
13.6.3 Five Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centres
13.10.3 Orthopaedic Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Viscosupplementation Market: Competitive Dashboard
14.2 Global Viscosupplementation Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Anika Therapeutics
14.3.2 Sanofi
14.3.3 Zimmer Biomet
14.3.4 Meda
14.3.5 Ferring
14.3.6 Fidia Pharmaceutici
14.3.7 Bioventus
14.3.8 Anika Therapeutics
